SCHEMBL32688045

SCHEMBL32688045

CCOC(=O)c1cccc(-c2cc(=O)[nH]c(S)c2C#N)c1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ACMSD Q8TDX5 1/20 0.46
▸ KDM4E B2RXH2 3/20 0.45
▸ RECQL P46063 1/20 0.45
▸ TDP1 Q9NUW8 1/20 0.45
▸ TP53 P04637 1/20 0.45
▸ POLB P06746 1/20 0.45
▸ HPGD P15428 1/20 0.45
▸ GLA P06280 1/20 0.44
▸ ATM Q13315 1/20 0.44
▸ ALDH1A1 P00352 3/20 0.43
▸ HTT P42858 1/20 0.43
▸ NPSR1 Q6W5P4 1/20 0.43
▸ RXFP1 Q9HBX9 1/20 0.43
▸ NPC1 O15118 1/20 0.41
▸ MAPT P10636 1/20 0.41
▸ RAB9A P51151 1/20 0.41
▸ SMN1; SMN2 Q16637 1/20 0.41
▸ GALR1 P47211 1/20 0.41
▸ TUBB4A P04350 1/20 0.41
▸ TUBB P07437 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL32687995 0.87 POLB (0.46) KDM4ERECQLTDP1POLBHPGD
SCHEMBL32688042 0.82 ACMSD (0.52) ACMSDKDM4ERECQLTDP1ATM
SCHEMBL32688102 0.78 ACMSD (0.41) ACMSDKDM4ETP53POLBHPGD
SCHEMBL8466650 0.77 ALDH1A1 (0.49) KDM4ETDP1TP53POLBHPGD
SCHEMBL20530634 0.77 NPC1 (0.47) ACMSDTP53POLBHPGDALDH1A1
SCHEMBL23183542 0.76 ACMSD (0.57) ACMSDKDM4ETDP1POLBHPGD
SCHEMBL32688038 0.76 ACMSD (0.45) ACMSDKDM4ETDP1POLBHPGD
SCHEMBL32688304 0.75 KDM4E (0.47) KDM4ERECQLTDP1HPGDALDH1A1
SCHEMBL32688076 0.74 KDM4E (0.50) ACMSDKDM4ERECQLTDP1HPGD
SCHEMBL20138013 0.73 ACMSD (0.71) ACMSDKDM4ETP53POLBHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260078105-A1 Novel Aminocarboxymuconate Semialdehyde Decarboxylase Inhibitors ORSOBIO INC (US) 2026-03-19 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260078105-A1 Novel Aminocarboxymuconate Semialdehyde Decarboxylase Inhibitors CPT1B, CBR1, MUSK ACMSD 142/4885KDM4E 3207/4885RECQL 1365/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback